Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Shareholders' Equity

v3.7.0.1
Consolidated Statements of Shareholders' Equity - 3 months ended Mar. 31, 2017 - USD ($)
$ in Thousands
Capital Stock
Warrants
Contributed Surplus [Member]
Accumulated Other Comprehensive Income
Deficit
Total
Beginning Balance at Dec. 31, 2016 $ 174,902 $ 4,109 $ 15,201 $ 3,604 $ (161,584) $ 36,232
Beginning Balance (in shares) at Dec. 31, 2016 143,676,384          
Exercise of stock options $ 517   (169)     $ 348
Exercise of stock options (in shares) 549,952         549,952
Common shares issued for cash, net $43 of issue costs $ 1,126         $ 1,126
Common shares issued for cash, net of issue costs (in shares) 1,536,169         1,536,169
Redemption of vested RSUs $ 75   (127)     $ (52)
Redemption of vested RSUs (in shares) 111,393          
Non-cash stock compensation     287     287
Net loss and comprehensive (loss) income       (11) 5,189 5,178
Ending Balance at Mar. 31, 2017 $ 176,620 $ 4,109 $ 15,192 $ 3,593 $ (156,395) $ 43,119
Ending Balance (in shares) at Mar. 31, 2017 145,873,898